An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Recruiting · NCT07593391 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome | Phelan-McDermid syndrome | Recruiting | Phase 3 | 2026-09-21 | NCT07593391 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Neuren Pharmaceuticals Limited | 2 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Neuren PMS-302 Site #116 | Birmingham | United States | 1 |
| Neuren PMS-302 Site#101 | New York | United States | 1 |
| Neuren PMS-302 Site#104 | Lexington | United States | 1 |
| Neuren PMS-302 Site#106 | Brookline | United States | 1 |
| Neuren PMS-302 Site#108 | Cincinnati | United States | 1 |
| Neuren PMS-302 Site#109 | Chevy Chase | United States | 1 |
| Neuren PMS-302 Site#111 | San Rafael | United States | 1 |
| Neuren PMS-302 Site#115 | Houston | United States | 1 |
| Neuren PMS-302 Site#122 | Glendale | United States | 1 |